Please join us for a webinar to share preliminary findings from the IMPAC19TB study
Join via Zoom:
Day 1:
https://mcgill.zoom.us/j/84197815674?pwd=OHNJM0IzQ3NJUlExWkxHYjB0MkxOQT09
Meeting ID: 841 9781 5674
Access password: 740706
Day 2:
https://mcgill.zoom.us/j/81800727968?pwd=eEZ6bXVxY0hhMmdhdml2UVJVbWVhUT09
Meeting ID: 818 0072 7968
Access password: 426773
Time: 13H00 – 15H00 (SAST)/08H00-10H00 (BRT)/18H00-20H00 (NOVT)/16H30-18H30 (IST)
Interpreters for Portuguese, Russian and Hindi will be available
| Day 1:
|
Thursday 10 March 2022 | Chairs:
Prof Anete Trajman Prof Anneke Hesseling |
| 13H00-13H10 | Welcome and opening | Prof Anneke Hesseling (Desmond Tutu TB Centre) |
| 13H10 – 13H30 | Keynote Address: Impact of COVID-19 on TB from a Global perspective | Dr Tereza Kasaeva
(WHO Director Global TB program) |
| 13H30 – 13H40
13H40 – 13H45 |
Epidemiological situation of tuberculosis in the context of the Covid-19 pandemic In Brazil and next steps planned.
Preliminary findings on TPT notification and outcomes in 5 cities in Brazil. |
Dr Kleydson Bonfim Andrade Alves
(Brazilian National TB Program)
lane Coutinho (PhD student) |
| 13H45 – 13H50
13H50 – 14H00 |
Impact of COVID-19 pandemic on TB epidemiological trends in most TB burden regions of Russia.
Genotypic characterization and drug resistance profiles of M. tuberculosis strains from Covid-19 patients |
Dr Yakov Schwartz
(Novosibirsk TB Research Institute)
Dr Igor Mokrousov (St. Petersburg Pasteur Institute) |
| 14H00 – 14H05
14H05 – 14H15 |
National TB programme response and resilience during COVID-19 Pandemic to mitigate its effect on NTEP in India
Molecular characterization of multi-drug resistant Tuberculosis isolates before and during COVID-19 pandemic |
Dr Kuldeep Sachdeva
(International Union Against Tuberculosis and Lung Diseases)
Prof Urvashi B Singh (All India Institute of Medical Sciences) |
| 14H15 – 14H30 | Impact of COVID-19 on the South African TB Care cascade: Preliminary results from the IMPAC19TB project | Dr Norbert Ndjeka
(South African National TB Program)
|
| 14H30 – 15H00 | Moderated Discussion | Chairs |
| Day 2:
|
Friday 11 March 2022 | Chairs:
Dr Yakov Schwartz Dr Urvashi Singh
|
| 13H00-13H10 | Welcome | Dr Graeme Hoddinott
(Desmond Tutu TB Centre) |
| 13H10-13H30 | Keynote address: Accessing TB services during COVID-19 – perspectives from a TB survivor | Mr. Carlos Duarte
(TB and COVID survivor) |
| 13H30 – 13H45 | The impact of COVID-19 on TB services in Brazil: users’ and healthcare workers’ perceptions | Ms Carla Almeida
(Federal University of Rio de Janeiro) |
| 13H45 – 14H00 | Provision of TB care in Russia during the COVID-19 pandemic: a view from inside. | Dr Irina Felker
(Novosibirsk TB Research Institute) |
| 14H00-14H15 | Perceptions of healthcare workers on the impact of COVID-19 on TB Care Services in India | Prof Anil Purty
(Pondicherry Institute of Medical Sciences) |
| 14H15 – 14H30 | Lessons from the COVID-19 response for the TB programme: Reflections from stakeholders in South Africa | Ms Hanlie Myburgh
(Desmond Tutu TB Centre) |
| 14H30 – 14H55 | Moderated Discussion | Chairs |
| 14H55 – 15H00 | Closing Remarks | Dr Sue-Ann Meehan
(Desmond Tutu TB Centre) |
